MedAdvisor Limited (AHE) Share Price & Analysis

AHE Stock Chart & Stats

A$0.01-A$0.00(-7.14%)

At close: Nov 02 12:03 PM GMT+11

Day’s Range: AUD 0.01 - AUD 0.01
52-Week Range: AUD 0.01 - AUD 0.03
Previous Close: AUD 0.01
Volume: N/A
Average Volume (3M): 312.78K
Market Cap: AUD 8.93M
Enterprise Value: -AUD 1.74M
Total Cash (Recent Filing): AUD 9.53M
Total Debt (Recent Filing): AUD 131.74K
Price to Earnings (P/E): ―
Beta: 1.42
Next Earnings: Mar 04, 2027 (Est.)
EPS Estimate: N/A
Next Dividend Ex-Date: N/A
Dividend Yield: N/A

Bulls Say, Bears Say

Bulls Say

Digital Platform Model

The platform serves several participants in the medication ecosystem, linking pharmacy communication, patient engagement, and pharmaceutical-brand content. This integrated model can support recurring digital interactions and create opportunities to deepen relationships across a focused healthcare network over the medium term.

Debt Reduction

Material debt reduction by 2026 is a constructive balance-sheet development because it can lower financing pressure and improve flexibility in allocating cash. Although negative equity remains a serious constraint, reduced debt provides some support for financial resilience during the next several quarters.

Prior Cash-generation Capability

Positive operating and free cash flow in 2024 shows that the business has demonstrated cash-generation capability under at least one reported period. While the pack describes this improvement as one-off, it identifies a potential operating base that management could seek to rebuild.

Bears Say

Revenue Deterioration

Repeated revenue declines indicate weakening commercial momentum and make it harder for the platform to spread fixed costs across a larger business. Without a sustained recovery in demand, the company has less capacity to fund product development, customer engagement, and future growth internally.

Persistent Unprofitability

Deep and continuing losses show that revenue is not currently converting into a sustainable earnings base. Negative gross profit in the latest periods is particularly concerning because it places pressure on the underlying economics of the offering and may require further funding before profitability can be achieved.

Negative Equity And Cash Burn

Negative equity combined with ongoing operating and free-cash-flow deficits materially limits financial flexibility. Continued cash burn can increase reliance on external funding, while the weakened capital base reduces the company’s ability to absorb further losses or invest consistently in its platform.

MedAdvisor Limited News

Adheris Health to Release Director Shares From Voluntary Escrow in November 2026

MedAdvisor Limited ( ($AU:AHE) ) just unveiled an announcement. Adheris Health Limited has advised that 1,750,000 fully paid ordinary shares will be released from voluntary escrow on 6 November 2026,

5d agoAHE

Adheris Health posts Q1 margin uplift as it pivots to higher-growth digital pharma programs

An update from MedAdvisor Limited ( ($AU:AHE) ) is now available. Adheris Health reported modest year-on-year revenue and gross profit growth for Q1 FY27, with a sharp rebound versus the

6d agoAHE

Adheris Health Dispatches AGM Documents and Promotes Digital Investor Communication

MedAdvisor Limited ( ($AU:AHE) ) has provided an update. Adheris Health Limited has dispatched key documents for its upcoming Annual General Meeting to shareholders, including the formal meeting notice, notice

2w agoAHE

Adheris Health aligns reporting calendar and shifts to U.S. dollar reporting

An update from MedAdvisor Limited ( ($AU:AHE) ) is now available. Adheris Health Limited has shifted its financial year-end from 30 June to 31 December to align its reporting cycle

3w agoAHE

EBOS Exits Substantial Holding in MedAdvisor’s Adheris Health Unit

MedAdvisor Limited ( ($AU:AHE) ) has shared an update. MedAdvisor’s subsidiary Adheris Health Limited is positioned in the health technology and pharmaceutical services industry, delivering digital adherence and patient engagement

1M agoAHE

Adheris Health Director Kate Hill Increases Direct Shareholding via Off-Market Trade

MedAdvisor Limited ( ($AU:AHE) ) has shared an update. Adheris Health Limited has disclosed a change in the holdings of director Catherine (Kate) Jane Hill, who increased her direct ownership

1M agoAHE

Adheris Health Leaders Boost Stakes as Insider Buying Signals Confidence

MedAdvisor Limited ( ($AU:AHE) ) has shared an update. Adheris Health has disclosed that its board and management have acquired about 27 million shares, equivalent to 4.2% of the company’s

1M agoAHE

Adheris Health Issues FY26 Results Presentation with Extensive Legal Disclaimers

MedAdvisor Limited ( ($AU:AHE) ) has provided an update. Adheris Health released its FY26 results presentation, framing the document as general information rather than investment advice and emphasizing that it

2M agoAHE

Adheris Health appoints new CFO to support U.S. rebuild and profitability push

An announcement from MedAdvisor Limited ( ($AU:AHE) ) is now available. Adheris Health Limited has appointed Alison Hale as Chief Financial Officer, effective 1 September 2026, replacing outgoing CFO Sean

2M agoAHE

Adheris Health Cuts Costs and Stabilises Cash Flow as Revenue Slides

MedAdvisor Limited ( ($AU:AHE) ) has shared an announcement. Adheris Health reported FY26 revenue of A$34.0 million from continuing operations, down 46% year on year, with gross profit and margins

2M agoAHE

AHE FAQ

What was MedAdvisor Limited’s price range in the past 12 months?

MedAdvisor Limited lowest share price was AU$0.01 and its highest was AU$0.03 in the past 12 months.

What is MedAdvisor Limited’s market cap?

MedAdvisor Limited’s market cap is AU$8.93M.

When is MedAdvisor Limited’s upcoming earnings report date?

The company’s upcoming earnings report date is not yet available.

How were MedAdvisor Limited’s earnings last quarter?

MedAdvisor Limited released its earnings results on Aug 30, 2026. The company reported -AU$0.043 earnings per share for the quarter.

Is MedAdvisor Limited overvalued?

Not enough analysts have published a price target to calculate whether the price is overvalued.

Does MedAdvisor Limited pay dividends?

MedAdvisor Limited does not currently pay dividends.

What is MedAdvisor Limited’s EPS estimate?

MedAdvisor Limited’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does MedAdvisor Limited have?

MedAdvisor Limited has 637,981,000 shares outstanding.

What happened to MedAdvisor Limited’s price movement after its last earnings report?

MedAdvisor Limited reported an EPS of -AU$0.043 in its last earnings report. Following the earnings report the stock price went same 0%.

Which hedge fund is a major shareholder of MedAdvisor Limited?

Currently, no hedge funds are holding shares in AU:AHE

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

MedAdvisor Limited Stock Smart Score

Neutral

Learn more about TipRanks Smart Score

Top Smart Score Stocks >

Company Description